Not a good buy right now for an impatient investor: the stock is extended short-term (RSI high) and upside looks limited versus recently raised Street targets.
Trend is bullish, but momentum is starting to cool (MACD histogram still >0 but contracting), which raises near-term pullback risk.
Biggest positive is heavy insider buying; biggest negatives are weak latest-quarter YoY earnings and lack of fresh catalysts/news.
Prefer waiting for a better entry closer to support (~27.22 pivot / ~25.80 S1) rather than buying at 27.74.
Technical Analysis
Current price: 27.7375 (+0.83%) while S&P 500 is -0.26% (relative strength today).
Trend: Bullish moving average stack (SMA_5 > SMA_20 > SMA_200) suggests an established uptrend.
Momentum: MACD histogram 0.211 (bullish) but positively contracting, signaling the up-move is losing steam.
RSI_6: 77.584 (effectively overbought/extended), which often precedes consolidation or a dip.
Key levels: Pivot 27.224 (nearby support). Resistance R1 28.646 then R2 29.523. Supports S1 25.803 and S2 24.926.
Near-term pattern-based odds provided: modest expected moves (+0.89% next day, +1.6% next week, +1.16% next month), not a high-conviction breakout setup at current price.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Open Interest Put-Call Ratio = 1.2 (more puts than calls outstanding) → mildly defensive/hedged sentiment.
Flow today: Option volume is extremely light (calls 11, puts 0; put-call volume ratio 0.0), so today’s tape gives limited sentiment signal.
Volatility: IV 30d ~52.23 vs HV ~55.23; IV percentile 5.58 and IV rank 15.27 suggest implied volatility is low relative to its own history (options relatively “cheap”), often consistent with calmer expectations after a move.
Technical Summary
Sell
1
Buy
10
Positive Catalysts
Insiders are buying: insider buying amount up ~306% over the last month (strong confidence signal).
Street pros view (pros): acknowledges improving tone after Q4 print; targets moved up, implying reduced downside concern.
Street cons view (cons): continued Neutral/Market Perform suggests limited conviction; importantly, the stock at ~27.74 is already above both cited targets ($27 and $25), implying constrained upside from here based on those benchmarks.
Influential/political trading: No recent congress trading data available (no signal from politicians).
Wall Street analysts forecast EGBN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EGBN is 18.5 USD with a low forecast of 18 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast EGBN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EGBN is 18.5 USD with a low forecast of 18 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
Current: 27.150
Low
18
Averages
18.5
High
19
Current: 27.150
Low
18
Averages
18.5
High
19
Piper Sandler
Neutral
maintain
$23 -> $27
AI Analysis
2026-02-02
Reason
Piper Sandler
Price Target
$23 -> $27
AI Analysis
2026-02-02
maintain
Neutral
Reason
Piper Sandler raised the firm's price target on Eagle Bancorp to $27 from $23 and keeps a Neutral rating on the shares. The firm thought Q4 results marked a sure positive, and the market clearly agreed with the stock popping after the print, now up 11% since the earnings report.
Keefe Bruyette
Catherine Mealor
Market Perform
maintain
$18 -> $25
2026-01-27
Reason
Keefe Bruyette
Catherine Mealor
Price Target
$18 -> $25
2026-01-27
maintain
Market Perform
Reason
Keefe Bruyette analyst Catherine Mealor raised the firm's price target on Eagle Bancorp to $25 from $18 and keeps a Market Perform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EGBN
